Bayer teams up with biotech firm Arvinas in deal worth up to $750 million
FRANKFURT (Reuters) - German drugmaker Bayer has signed an alliance with Arvinas Inc to gain access to the U.S. biotech firm’s experimental protein drugs and crop protection technology in a deal worth up to $750 million. Under the pact, Arvinas will receive…
bubmagJune 4, 2019